GCC Palliative Care — Symptom Management Nursing Guide 2026

Comprehensive reference for DHA · MOH · SCFHS · QCHP — Palliative Care Nursing

WHO Analgesic Ladder

Step 1 — Non-Opioid (Mild Pain, NRS 1–3)

Paracetamol 1g q6h regular + NSAID (ibuprofen/naproxen) if no contraindication. Adjuvants as indicated. Goal: maintain function.

Step 2 — Weak Opioid (Moderate Pain, NRS 4–6)

Codeine 30–60mg q4–6h or tramadol 50–100mg q6h (caution: serotonin syndrome risk). Continue non-opioid + adjuvants. Reassess in 24–48h.

Step 3 — Strong Opioid (Severe Pain, NRS 7–10)

Oral morphine (immediate-release) 5–10mg q4h regular + breakthrough PRN. Titrate: increase by 30–50% if ≥3 breakthroughs/24h. Once stable, convert to modified-release (MR) twice daily.

Note: Move up the ladder if pain not controlled within 24–48h. Use adjuvants at every step as clinically indicated.

Morphine Equivalency Conversions

ConversionFactor / FormulaExample
Oral morphine → IV/SC morphine÷ 330mg oral = 10mg SC/IV
Oral morphine → SC diamorphine÷ 330mg oral = 10mg SC diamorphine
Oral morphine → Fentanyl patch (mcg/hr)÷ 100100mg oral = 25mcg/hr patch
Oral morphine → Oral oxycodone× 0.7530mg oral morphine = 20mg oral oxycodone
Oral oxycodone → Oral morphine× 1.3320mg oral oxycodone = 26.6mg oral morphine
IV/SC morphine → Oral morphine× 310mg SC = 30mg oral
Cross-Tolerance Reduction: When switching opioids, reduce calculated equianalgesic dose by 25–30% to account for incomplete cross-tolerance, then titrate up as needed.

Breakthrough Dose Calculation

Rule: 1/6 of Total 24h Opioid Dose

Example: Patient on morphine MR 60mg twice daily (120mg/24h) → Breakthrough = 120 ÷ 6 = 20mg oral morphine PRN q1–4h

SC equivalent = 20 ÷ 3 = ~7mg SC morphine PRN

Reassessment Rule

  • If ≥3 breakthrough doses used in 24h → increase regular dose by 30–50%
  • Add all breakthrough doses used to new 24h total, recalculate 1/6

Pain Assessment Tools

ESAS — Edmonton Symptom Assessment Scale

0–10 NRS for: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, breathlessness. Completed by patient; used for monitoring trends.

PAINAD (Non-Verbal / Dementia)

  • Breathing (independent of vocalisation)
  • Negative vocalisation
  • Facial expression
  • Body language
  • Consolability

Score 0–10. Score ≥3 indicates significant pain requiring intervention.

Adjuvant Analgesics

Neuropathic Pain
First Line

Amitriptyline 10–25mg nocte (titrate to 75mg). Anticholinergic SEs; avoid in cardiac disease.

First Line (Alternative)

Pregabalin 25–75mg BD, titrate to 300mg BD. Better tolerated than gabapentin (linear pharmacokinetics).

Alternative

Gabapentin 100–300mg TDS, max 3600mg/day. Dose-reduce in renal impairment.

Bone Pain
NSAIDs

Ibuprofen / diclofenac / naproxen. Effective for bone metastases. Use with PPI cover. Avoid in renal impairment, GI bleed history.

Bisphosphonates

Zoledronic acid IV 4mg q4 weeks. Reduces skeletal events, analgesic effect within 2–4 weeks. Monitor renal function; risk of osteonecrosis of jaw.

Radiotherapy

Single fraction (8Gy) as effective as multiple fractions for painful bone metastases. Response rate ~60–70%. Onset: 2–4 weeks.

Other Adjuvants
Corticosteroids

Dexamethasone 4–8mg daily. Useful for: nerve compression, raised ICP, liver capsule pain, bone pain. Short course to minimise SE.

Ketamine

Low-dose SC infusion for refractory neuropathic/opioid-resistant pain. Specialist use. Dissociative SEs; concurrent benzodiazepine may be needed.

Muscle Spasm

Baclofen 5–10mg TDS or diazepam 2–5mg TDS for muscle spasm component.

Dyspnoea Management — Opioids

Evidence-Based: Low-Dose Morphine

Oral: Morphine immediate-release 2.5–5mg q4h regular + 2.5mg PRN for breakthrough breathlessness

SC: Morphine 2.5–5mg q4h SC or via syringe driver

Opioid-naive: start 2.5mg, titrate cautiously. Already on opioids: increase current dose by 25–30%.

Low-dose opioids do NOT cause clinically significant respiratory depression at appropriate palliative doses — this is a common misconception.

Mechanism

  • Reduce central perception of breathlessness
  • Reduce ventilatory drive and O2 consumption
  • Anxiolytic effect reduces dyspnoea perception

Non-Pharmacological Management

Positioning

Upright/semi-recumbent. Lean forward with arms supported (tripod). Reduces work of breathing.

Fan / Cool Air

Handheld fan directed to face — stimulates trigeminal nerve facial receptors → reduces breathlessness perception. Evidence Level: strong RCT evidence.

Pacing & Activity Modification

Occupational therapy input. Energy conservation techniques. Prioritise meaningful activities.

Anxiety Management

Breathing techniques (pursed-lip, diaphragmatic). Relaxation. Lorazepam 0.5mg SL for acute anxiety component.

Oxygen Therapy — When to Use

Oxygen is NOT a default for dyspnoea in palliative care. Evidence shows air/fan is equally effective in non-hypoxic patients. Oxygen is indicated only if SpO2 <88% at rest, or symptomatic response confirmed.

Indications (Oxygen)

  • SpO2 <88% on room air at rest
  • Symptomatic improvement objectively confirmed
  • COPD with hypoxic drive — use controlled 24–28%

Do Not Use Oxygen If:

  • SpO2 ≥92% — no benefit, may cause distress (mask)
  • Dying patient who is not distressed
  • Patient preference against

Death Rattle (Noisy Breathing at End of Life)

Caused by accumulation of secretions in hypopharynx in semi-conscious/unconscious patients. Distressing for family; usually not distressing to patient.

Non-Pharmacological

  • Repositioning (lateral/semi-prone)
  • Explain to family: patient likely not distressed
  • Gentle oral suction only if distress evident
  • Reduce IV fluids if contributing

Pharmacological (Antisecretory)

Glycopyrronium 200mcg SC/IV q4h PRN

Does not cross BBB → less CNS effect. Preferred in patients where sedation is undesirable. Max 800mcg/24h.

Hyoscine Butylbromide (Buscopan) 20mg SC q4h

Antisecretory + antispasmodic. Does not cross BBB. Compatible in syringe driver. 60–120mg/24h.

Hyoscine Hydrobromide 400mcg SC q4h

Crosses BBB → additional sedation. Used when sedation acceptable. Less preferred first-line.

Syringe Driver — Setup Principles

Indications

  • Unable to swallow oral medications
  • Persistent nausea/vomiting
  • Intestinal obstruction
  • Last days of life care

Key Setup Points

  • Use water for injection (NOT saline) for diamorphine compatibility
  • Run over 24 hours (CADD, Graseby, or equivalent)
  • Change every 24h; inspect site q4h
  • Never mix more than 3 drugs without compatibility check
  • Label clearly with drug names, doses, diluent

Compatible Combinations (Common)

Standard End-of-Life Driver

Diamorphine + Midazolam + Glycopyrronium — compatible in WFI

Nausea/Obstruction

Morphine + Cyclizine + Hyoscine butylbromide — check concentration-dependent compatibility

Incompatible

Cyclizine precipitates at higher concentrations. Dexamethasone — use separate syringe unless diluted with large volume.

Pleural Effusion

ManagementIndicationNotes
Therapeutic thoracocentesisSymptomatic, first presentationRelief for 2–4 weeks; recurs in ~98% malignant effusions
Pleurodesis (talc)Recurrent effusion, good PSTalc slurry or poudrage; 70–80% success rate; painful — premedicate with opioid
Indwelling pleural catheter (IPC)Trapped lung, recurrent or poor PSHome drainage; quality of life improvement
Symptom management onlyVery poor PS, patient choiceOpioids, fan, positioning — prioritise comfort

Anti-emetic Selection by Cause

CauseMechanismDrug of ChoiceDose
Opioid-induced (early)CTZ dopamine stimulationHaloperidol0.5–1.5mg SC nocte or BD
Gastric stasis / partial obstructionReduced gastric motilityMetoclopramide10mg TDS–QDS oral/SC (prokinetic)
Vestibular / motionH1 + muscarinicCyclizine50mg TDS oral/SC/IV
Raised intracranial pressureVomiting centreCyclizine + dexamethasoneCyclizine 50mg TDS + Dexa 8–16mg/day
Metabolic (hypercalcaemia, uraemia)CTZ dopamine/5HT3Haloperidol or ondansetronHaloperidol 1.5mg nocte
Intractable / refractoryMultiple receptorLevomepromazine6.25–12.5mg SC nocte or BD
Chemotherapy-induced5HT3 (gut) + CTZOndansetron ± dexamethasone8mg BD–TDS oral/IV

Malignant Bowel Obstruction (MBO)

Avoid metoclopramide in COMPLETE obstruction — prokinetic effect against obstruction causes colicky pain. Use only in functional/partial obstruction.

Surgical Consideration

  • Multidisciplinary decision based on PS, prognosis, patient wishes
  • Stenting for single-site colonic obstruction
  • Venting gastrostomy for high small bowel obstruction

Medical Management

  • NG tube: short-term decompression (not long-term)
  • IV/SC fluids: symptom-based decision, not reflex
  • Mouth care essential

Syringe Driver for MBO

Standard MBO Driver (24h)

Morphine/Diamorphine (pain)

+ Cyclizine 150mg (nausea — antiemetic)

+ Hyoscine butylbromide 60–120mg (reduces secretions, colic)

+ Dexamethasone 4–8mg (reduces peritumour oedema — separate syringe)

Octreotide 300–600mcg/24h SC can reduce GI secretions in high-output obstruction — consider in intractable vomiting.

Constipation — Opioid-Induced

Opioid-induced constipation (OIC) does NOT develop tolerance — laxatives must be prescribed with every opioid, always. Reassess bowel function at every review.

First-Line Laxative Regimen

Combination: Stimulant + Osmotic

Senna 2 tablets BD (stimulant — colonic peristalsis)

+ Lactulose 15–30ml BD (osmotic softener)

Or: Co-danthramer 1–3 capsules nocte (both actions combined)

Second Line

  • Macrogol (Movicol) 1–3 sachets daily for impaction
  • Rectal: glycerine suppositories / phosphate enema

Peripheral Opioid Antagonists (OIC-Specific)

Methylnaltrexone (Relistor)

SC injection every other day. Acts peripherally (does not cross BBB) → no reversal of central analgesia. Use when conventional laxatives fail. Dose: weight-based ~8–12mg SC.

Naloxegol / Naldemedine

Oral peripheral opioid antagonists. Not universally available in GCC — check local formulary.

Cancer-Related Cachexia & Anorexia

Pharmacological (Short-Term)

Corticosteroids (1–4 weeks)

Dexamethasone 2–4mg daily or prednisolone 15–30mg daily. Improves appetite and well-being; effect wanes after ~4 weeks. Use short-term to avoid SE (myopathy, Cushing's).

Megestrol Acetate

160–800mg daily. Appetite stimulant. Thromboembolic risk. Less evidence for actual weight gain. Not first-line.

Non-Pharmacological

  • Small frequent meals, patient preference foods
  • Dietary counselling (RD referral)
  • Oral nutritional supplements
  • Address contributing factors: depression, nausea, pain, oral problems
  • Oral hygiene and mouth care

Family Education

Explain that reduced intake is part of the dying process — not the cause of death. Forced feeding causes distress. Presence and comfort more important than calories.

Anxiety Management

Non-Pharmacological (First-Line)

CBT/brief psychological therapy, relaxation, mindfulness, guided imagery, chaplaincy, peer support. Addressing unmet needs (information, family concerns).

Benzodiazepines (Pharmacological)

Lorazepam 0.5–1mg SL/oral PRN for acute anxiety/panic. Onset 15–30min SL.

Diazepam 2–5mg oral TDS for generalised anxiety. Long half-life — use with caution in elderly/hepatic impairment.

Midazolam 2.5–5mg SC PRN or 10–30mg/24h SC infusion for terminal agitation.

Depression in Palliative Care

Standard PHQ-9 may over-diagnose depression due to somatic overlap with cancer symptoms. Consider single-item "Are you depressed?" screening and clinical judgement.

Pharmacological

Mirtazapine 7.5–30mg Nocte (Preferred)

Benefits: appetite stimulation + sedation (especially at low doses) + antidepressant. Useful in anorexia/insomnia. Onset: 1–2 weeks. Well-tolerated.

SSRIs (If Longer Prognosis >4 weeks)

Sertraline 50mg daily (best tolerated). Onset 2–4 weeks — use if prognosis allows. Citalopram 10–20mg if drug interactions concern.

Methylphenidate (Short Prognosis)

Psychostimulant. 2.5–5mg AM + 2.5mg noon. Rapid onset (days). Use in refractory depression with short prognosis where waiting weeks for SSRI not possible.

Delirium at End of Life

Recognition

  • Acute onset, fluctuating course
  • Inattention, disorganised thinking
  • Altered level of consciousness
  • Hyperactive (agitation), hypoactive (quiet confusion), or mixed

Reversible Causes (Screen)

  • Urinary retention / constipation
  • Pain (under-treated)
  • Opioid toxicity (reduce + rotate)
  • Infection (treat if appropriate to goals)
  • Metabolic: hypercalcaemia, uraemia, hyponatraemia
  • Steroid-induced, medication side effects

Pharmacological Management

Haloperidol — First-Line

0.5–2mg SC/oral q4–8h PRN. For mild–moderate delirium. Titrate cautiously in elderly. Avoid in Lewy body dementia (severe EPS).

Midazolam — Refractory/Terminal Agitation

2.5–5mg SC PRN or 10–60mg/24h SC infusion. Used when haloperidol insufficient or for palliative sedation. May cause paradoxical agitation — monitor.

Levomepromazine — Alternative

12.5–25mg SC q4–8h. Broad-spectrum (D2+H1+5HT2+alpha). Sedating — useful when sedation desired. Compatible in syringe driver.

Existential Distress

  • Meaning-making and purpose concerns
  • Fear of dying process (not death per se)
  • Loss of dignity, identity, autonomy
  • Unfinished business, regrets, reconciliation needs

Interventions

  • Dignity Therapy — structured narrative interview; patient tells life story; edited transcript given to family. Evidence for dignity/meaning.
  • Meaning-Centred Psychotherapy — 7-session structured intervention
  • Life Review — narrative approach, guided reminiscence
  • Chaplaincy referral — Islamic/other faith traditions

Islamic Chaplaincy & Spiritual Care

  • Encourage recitation of Shahada / Surah Yaseen by patient or family
  • Prayer (Salah) accommodations: bed-positioning, tayammum (dry ablution)
  • Qibla direction (facing Mecca) in room layout
  • Facilitate imam/chaplain visits; document in care plan
  • Privacy for family prayer and Quranic recitation
  • Address patient/family concerns about opioids (halal status) — educate: use of medications for pain relief is permitted in Islam
  • Ramadan: assess fasting intention; medications via SC/patch/suppository to accommodate fasting

Anticipatory Grief

  • Normalise grief responses pre-bereavement
  • Bereavement risk screening (VOICES, family complexity assessment)
  • Signpost bereavement support (Islamic bereavement counselling if available)
Accordion: Algorithms & Checklists
Terminal Agitation Management Algorithm ▶

Step 1 — Assess & Treat Reversible Causes

  • Urinary retention → catheterise
  • Constipation → rectal intervention
  • Pain → increase/add opioid
  • Opioid toxicity (myoclonus/hallucinations) → opioid rotation + reduce dose
  • Hypercalcaemia → IV bisphosphonate if appropriate to goals

Step 2 — Non-Pharmacological

  • Calm environment, reduce stimulation, familiar family presence
  • Soft lighting, reduce unnecessary observations/interventions
  • Reorient gently (do not argue with hallucinations)
  • Explain to family: terminal restlessness is process, not pain

Step 3 — Pharmacological (Mild)

  • Haloperidol 0.5–1mg SC q4h PRN (hyperactive delirium)
  • Lorazepam 0.5–1mg SL PRN (anxiety component)

Step 4 — Pharmacological (Moderate–Severe / Refractory)

  • Midazolam 2.5–5mg SC PRN, up to 10–60mg/24h via syringe driver
  • Combine haloperidol + midazolam in driver if needed
  • Levomepromazine 25–50mg/24h SC as alternative to midazolam

Step 5 — Palliative Sedation (Last Resort)

  • Refractory suffering not responsive to other interventions
  • MDT decision + family consent + documentation
  • Proportionate sedation — lightest level achieving comfort
  • Continue mouth care, pressure care, family presence

Recognition of the Dying Phase (NICE NG31)

Diagnosis of dying requires clinical judgement — no single sign is absolute. All four criteria should be considered together. Reversible causes must be excluded.

Five Key Markers

Bedbound — Unable to get out of bed, profound weakness
Semi-conscious / drowsy — Only rousable to voice, unable to maintain conversation
Only able to take sips — Significant dysphagia, not drinking adequately
Not taking oral medications — Unable to swallow tablets reliably
Peripheral shutdown — Mottled skin, cool extremities, Cheyne-Stokes breathing

Other Signs to Document

  • Oliguria / dark urine or cessation of urine output
  • Irregular breathing pattern, apnoeic pauses
  • Jaw relaxation, sunken eyes
  • Death rattle / secretions
  • Loss of radial pulse
  • Profound pallor

Documentation

  • Record clinical assessment in notes
  • Inform MDT, family, and GP
  • Review all active treatment orders — discontinue inappropriate interventions
  • Commence anticipatory prescribing

Anticipatory Prescribing (Pre-Emptive)

Prescribe anticipatory medications before they are needed — do not wait for symptoms to develop. Medications should be written, drawn up, and ready at bedside.
SymptomDrugRouteDose (Opioid-Naive)Frequency
Pain / BreathlessnessMorphine sulfateSC2.5–5mgq4h PRN
Agitation / AnxietyMidazolamSC2.5–5mgq4h PRN
Nausea / VomitingHaloperidol or cyclizineSC0.5–1.5mg / 50mgq6–8h PRN
Respiratory secretionsGlycopyrroniumSC200mcgq4h PRN
Agitation (severe)LevomepromazineSC12.5–25mgq8h PRN

Syringe Driver — Last Days Combinations

Standard Comfort Driver (24h — SC)

Diamorphine (pain/breathlessness): dose based on prior opioid use or 10–20mg opioid-naive

+ Midazolam 10–20mg (agitation/anxiety)

+ Glycopyrronium 600–1200mcg (secretions)

Diluent: Water for Injection (WFI) — do NOT use saline with diamorphine

If Nausea Prominent

Add Haloperidol 2–5mg/24h or Levomepromazine 25mg/24h

If Morphine Used Instead of Diamorphine

Morphine + Midazolam + Glycopyrronium — compatible in WFI. Note morphine : diamorphine oral equivalence = 3:1

Check compatibility before combining. Use Palliative Care formulary or Palliativedrugs.com. Never mix >3 drugs without specialist advice.

Mouth Care

  • Frequency: q2–4h and PRN
  • Foam swabs moistened with water
  • Apply petroleum jelly/lip balm to lips
  • Small sips of preferred fluid if swallowing safe
  • Nystatin oral drops for oral candidiasis
  • Involve family — meaningful role in care
  • Document oral assessment (Oral Assessment Guide)

Pressure Area Care

  • Waterlow / Braden score assessment
  • Turning q2–4h (if tolerated/not distressing)
  • Pressure-relieving mattress (dynamic air)
  • Skin inspection and moisture barrier cream
  • In last hours: comfort overrides pressure care schedule — avoid distressing turns
  • Kennedy Terminal Ulcer: skin breakdown in dying — educate family; not preventable

Family Communication at End of Life

Verification & Certification of Death

Verification of Death (Nursing / Medical)

  • Absence of respiratory effort (1 minute)
  • Absence of central pulse (carotid — 1 minute)
  • Absence of heart sounds (1 minute auscultation)
  • Fixed, dilated pupils
  • No response to verbal or painful stimulus
  • Note time of death; document in notes

After Death Care (GCC)

  • Notify doctor to certify death and complete death certificate
  • Allow family time with body before moving
  • Body laid straight; eyes closed
  • In Muslim patients: face body toward Qibla (Mecca) if possible; family notified for ritual washing (ghusl)
  • Personal belongings documented and returned to family
  • Staff debrief / emotional support offered
Islamic End-of-Life Care Checklist for Nursing Staff ▶

Before Death — Active Dying Phase

Inform family immediately — large family presence is culturally normative and should be facilitated
Facilitate Quranic recitation (Surah Yaseen) at bedside — provide privacy
Guide patient/family to recite Shahada: "La ilaha illallah" if patient is conscious
Reposition patient to face Qibla (toward Mecca) — check room orientation or use compass
Remove all non-essential lines/equipment if death is confirmed imminent and patient wishes allow
Ensure adequate privacy for family prayer (salah) — identify prayer room location
Chaplain/Imam notified and visit facilitated
No non-Muslim staff to touch body without gloves (respect for ritual purity)

After Death

Close eyes (traditionally done by family member reciting "Bismillah")
Close mouth — support chin with bandage if needed
Straighten limbs; lay hands across chest or at sides
Maintain dignity — cover body; limit staff entering room
Body handed to family for ritual washing (ghusl) and shrouding (kafan) — usually same-sex family members
Burial within 24 hours is religious obligation — expedite death certificate and release process
Autopsy: accepted only if legally required (Islamic law permits when legally mandatory)
Organ donation: permitted under fatwa in some GCC countries (Saudi — permitted; UAE — permitted with conditions). Discuss sensitively.
Syringe Driver Compatible Drug Combinations Reference ▶
CombinationCompatibilityDiluentNotes
Diamorphine + MidazolamCompatibleWFIStandard end-of-life combination
Diamorphine + GlycopyrroniumCompatibleWFIStandard secretion control
Diamorphine + HaloperidolCompatibleWFINausea/agitation control
Diamorphine + LevomepromazineCompatibleWFISedating antiemetic/agitation
Morphine + Midazolam + GlycopyrroniumCompatibleWFI or 0.9% NaClAlternative if no diamorphine
Cyclizine + Diamorphine (high dose)CautionWFIMay precipitate at high concentrations; use lowest effective doses
Dexamethasone + any opioidAvoid—Precipitates; use separate syringe/IV line
Diazepam (IV) + opioidsAvoid—Use midazolam instead for SC; diazepam not suitable for SC
Ketamine + Morphine + MidazolamCompatibleWFIRefractory pain; specialist initiation only
Octreotide + MorphineCompatible0.9% NaClMBO; use saline for octreotide

Always check with pharmacist or Palliativedrugs.com for specific concentration-dependent compatibility. This table is for guidance only.

Islamic Jurisprudence & End-of-Life Decisions

Withdrawal of Futile Treatment (Fatwa)

Islamic jurisprudence (fiqh) permits withdrawal or withholding of futile medical treatment. The Islamic Fiqh Academy (Mecca, 1986) resolution states: life support may be withdrawn when three specialist physicians confirm the condition is irreversible. Death with dignity is an Islamic value.

Opioids in Islamic Law

Use of opioids for pain relief is permissible (halal) under the principle of necessity (daroura). Addiction is not a concern in terminal illness. Nurses should proactively address family fears about opioid use.

Euthanasia & Assisted Dying

Strictly prohibited in Islamic jurisprudence. Palliative care intention is comfort — not hastening death (doctrine of double effect applies but should be framed in Islamic terms).

Islamic Death Rituals — Nursing Guide

Facing Mecca (Qibla)

Dying patient should be positioned on right side or supine facing Mecca. Nurses can use a compass app. Document family preferences.

Tahleel Prayer

Family/imam recites "La ilaha illallah" — there is no god but Allah — as patient dies. Ensure quiet, privacy, and do not interrupt.

Closing Eyes

Eyes closed by family member after death while reciting supplication. Nursing staff should ask family if they wish to perform this.

Ghusl (Ritual Washing)

Body washed by same-sex Muslim family members or trained Muslim healthcare workers. Nursing role: provide privacy, warm water, clean environment. Kafan (white shroud) applied.

Burial

Within 24 hours — religious obligation. Nurses should flag to ward coordinator to expedite documentation and body release processes.

GCC Palliative Care Development

Saudi Arabia (MOH / SCFHS)

  • National Palliative Care Program within MOH — hospital-based services in major cities
  • King Faisal Specialist Hospital (KFSH&RC) — leading palliative care centre
  • SCFHS: Saudi Commission for Health Specialties — regulates nursing competency and certification
  • Palliative care integrated into Vision 2030 healthcare reform
  • Home-based palliative services expanding in Riyadh, Jeddah

Qatar (QCHP / HMC)

  • Qatar Council for Healthcare Practitioners (QCHP) — nursing licensure
  • Hamad Medical Corporation (HMC) — national provider, palliative care unit established
  • National Cancer Care Program integrates palliative services

UAE (DHA / HAAD / DOH)

  • Dubai Health Authority (DHA) — palliative care standards and licensing
  • Department of Health Abu Dhabi (DOH) — separate regulations
  • Palliative care centres at Dubai Hospital, Rashid Hospital, Cleveland Clinic Abu Dhabi
  • Home palliative care services growing — VPS Healthcare, LLH Hospital

Bahrain / Kuwait / Oman

  • Earlier stage of palliative care development
  • Hospital-based services primarily — inpatient consult model
  • Increasing training and awareness programs
  • WHO and IAHPC (Int'l Assoc. for Hospice & Palliative Care) supporting development

Opioid Prescribing Regulations in GCC

GCC countries have strict opioid prescribing regulations that can create barriers to adequate pain control. Nurses must be aware and advocate for patients.
CountryControlled Drug RegulationsImpact on Palliative Care
Saudi ArabiaSchedule 1 narcotics — requires specific narcotics prescription pad; limited quantity per prescription; triplicate formsDelays in titration; under-prescribing common; KFSH has improved access protocols
UAE (DHA)Controlled drugs require DHA-approved prescriber; strict dispensing records; quantity limitsHomecare opioids challenging; palliative care prescribers can apply for exemption
QatarHMC internal protocols for controlled drugs; relatively better hospital accessCommunity prescribing limited; mostly inpatient access
KuwaitVery restrictive — opioids often only inpatient; limited community accessSignificant barrier to home palliative care and adequate terminal pain control
OmanImproving — MOH efforts to increase opioid availabilityBetter than Kuwait; still challenges in rural/community settings

SCFHS Palliative Care Nursing Competencies

Core Competency Domains

  • Domain 1: Palliative care principles and philosophy
  • Domain 2: Pain and symptom management
  • Domain 3: Communication and advance care planning
  • Domain 4: Psychosocial, cultural and spiritual care
  • Domain 5: End-of-life care
  • Domain 6: Family-centred care and bereavement
  • Domain 7: Ethical and legal issues
  • Domain 8: Palliative care across the lifespan (paediatric)

Exam Preparation Tips

  • WHO analgesic ladder — must know 3 steps and drugs at each
  • Opioid conversions — high-frequency exam topic
  • Anticipatory prescribing — 4 drug classes and indications
  • Islamic end-of-life care — culturally specific GCC question
  • Syringe driver compatibility — practical clinical question
  • ESAS assessment tool — know all 9 symptoms
  • Recognising dying — NICE NG31 five criteria
  • Death rattle management — glycopyrronium vs hyoscine

Ramadan & Symptom Management

Medication Routes During Fasting

Permitted (Do Not Break Fast)

SC/IM/IV injections (not nutritive), transdermal patches, topical creams, eye/ear/nose drops, suppositories, inhalers (most scholars). Consult patient/family regarding their followed scholarly opinion.

Break the Fast

Oral medications, oral nutritional supplements, IV glucose/nutritive fluids, NG feeds.

Nursing Approach

  • Assess patient's intention regarding fasting — seriously ill patients have Islamic permission (rukhsa) to not fast
  • Educate: Islam permits not fasting during severe illness; fasting may be made up later or fidya (expiation) paid
  • Explore medication alternatives: transdermal fentanyl, SC syringe driver, suppositories during fasting hours
  • Cluster oral medications to non-fasting hours (sunset to dawn) where possible
  • Monitor for dehydration, hypoglycaemia
  • Involve imam/chaplain if patient conflicted about fasting vs medication
GCC Exam Prep — MCQ Practice (DHA / MOH / SCFHS / QCHP Style)
Q1. A patient on oral morphine 90mg/24h requires conversion to a subcutaneous syringe driver using diamorphine. What is the correct 24-hour diamorphine dose?
C — 30mg. Oral morphine ÷ 3 = SC diamorphine. 90mg ÷ 3 = 30mg/24h diamorphine. Breakthrough dose = 30 ÷ 6 = 5mg SC diamorphine PRN.
Q2. A Muslim patient is actively dying. The family requests that the patient be positioned facing Mecca and that a chaplain be called. Which nursing action is MOST appropriate?
B — Respecting religious and cultural wishes is a core palliative care nursing competency. The nurse should reposition the patient toward Mecca (using compass if needed), facilitate chaplain contact, and document the family's wishes in the nursing care plan.
Q3. A patient with a malignant bowel obstruction has been started on metoclopramide for nausea. The nurse notices increasing abdominal colic. What is the MOST likely cause?
B — Metoclopramide is a prokinetic agent. In complete bowel obstruction, it stimulates bowel contraction against the obstruction, causing severe colic. It must be discontinued. Appropriate management includes a syringe driver with morphine/diamorphine + cyclizine + hyoscine butylbromide (antisecretory, antispasmodic).
Q4. According to Islamic jurisprudence as applied in GCC healthcare settings, which of the following statements about withdrawal of life-sustaining treatment is CORRECT?
B — The Islamic Fiqh Academy (Mecca, 1986) resolution permits withdrawal of life-sustaining treatment when futile, confirmed by three specialist physicians. The principle upheld is that treatment is obligatory only when it offers benefit. Withdrawing futile treatment is not equivalent to euthanasia.
Q5. A patient in the last 48 hours of life develops noisy, gurgling breathing (death rattle). Family members are distressed. Which is the PRIORITY nursing intervention?
C — Priority is family education and comfort. Death rattle is caused by pooled secretions in the unconscious patient and is usually not distressing to the patient. Repositioning (lateral/semi-prone) may reduce noise. Glycopyrronium 200mcg SC is the antisecretory drug of choice. Aggressive suctioning causes distress and is not effective for deep secretions. IV fluids may worsen secretions.

Opioid Conversion & Breakthrough Dose Calculator

Clinical Tool Only. Always verify calculations with a second checker and prescriber before administration. Apply 25–30% dose reduction for cross-tolerance when switching opioids.
24h Oral Morphine Equivalent
—
Total equianalgesic oral morphine
Target Equianalgesic Dose (24h)
—
Full equianalgesic dose (24h)
Recommended Starting Dose (24h)
—
75% of equianalgesic (25% cross-tolerance reduction)
Breakthrough Dose (PRN)
—
1/6 of recommended 24h dose
Max Breakthroughs / 24h
6
Review regular dose if ≥3 used/24h
GCC Palliative Care Nursing Guide — For educational and clinical reference use. Always follow local hospital protocols, prescriber orders, and verify drug compatibility with pharmacy.
References: WHO Analgesic Ladder · NICE NG31 · Palliative Care Formulary (PCF) · SCFHS Competency Framework · Islamic Fiqh Academy Resolutions · IAHPC GCC Reports